Samith Sandadi, MD
Gynecologic Oncology · Fort Myers, FLNPI 1790980142
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (42.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 60.9% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $20,651 and has fallen 98.0% since, to $405 in 2025.
Across 231 payments — averaging $121.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$17K
- Tesaro, Inc.$6K
- GSK$946
- Merck$652
- AstraZeneca$646
- Eisai Inc.$426
- plus $2K from 23 others
What the payments were for
- Consulting fees$4,70017%
- Travel & lodging$5,31519%
- Food & beverage$6,02421%
- Education$12,00043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 42 | $17,066 |
| Tesaro, Inc. | 10 | $5,974 |
| GSK | 38 | $946 |
| Merck | 27 | $652 |
| AstraZeneca | 22 | $646 |
| Eisai Inc. | 11 | $426 |
| Clovis Oncology, Inc. | 17 | $398 |
| Myriad Genetic Laboratories, Inc. | 12 | $318 |
| Baxter Healthcare | 6 | $288 |
| AbbVie | 8 | $235 |
| Johnson & Johnson | 4 | $215 |
| Seagen Inc. | 12 | $212 |
| Medical Device Business Services, Inc. | 2 | $203 |
| Genentech USA, Inc. | 2 | $78 |
| Pfizer | 3 | $76 |
| Tempus AI, Inc | 2 | $41 |
| Momentis Surgical Inc. | 1 | $40 |
| Distalmotion US | 1 | $26 |
| Immunogen, Inc. | 1 | $23 |
| KCI USA, Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Novartis | 1 | $20 |
| Caris MPI, Inc. | 1 | $20 |
| Fennec Pharmaceuticals, Inc. | 1 | $17 |
| Medtronic | 1 | $17 |
| Solventum Corporation | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Coopersurgical, Inc. | 1 | $15 |
| Teleflex LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$16,242
- ZEJULA$5,785
- LYNPARZA$215
- Rubraca$122
- KEYTRUDA$110
How this compares
$28,039 in reported general payments places this provider in the 75th percentile of 117 gynecologic oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 17 | $263 |
| Ondansetron Hcl | 17 | $224 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 49 | $169 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $76 |
| Tramadol Hcl | 43 | $69 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Fort Myers
- Edward GrendysFort Myers$341K
- Fadi Abu ShahinFort Myers$121K
- Bradley MonkWest Palm Beach$2.5M
- Martin MartinoJacksonville$957K
- Brian SlomovitzFort Lauderdale$519K
- Ricardo EstapeMiami$457K
- Robert HollowayOrlando$432K
- Shelly SewardOrlando$349K
- Jonathan BlackMiramar$329K
- Nathalie McKenzieOrlando$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.